Session 994: Gene Therapy, Part 1
Cochair(s): C Baum, S Ikehara
Date: Sat 9 February 2002,
Time: 14:00 - 16:00
Location: CIS Auditorium
Oral Presentations
| Time |
Number |
Title / Authors / Affiliations |
| 14:00 |
502 |
Horizontal gene
transfer: implications for tumor
progression.
L Holmgren
Karolinska Institute,
Stockholm, Sweden Sweden |
| 14:15 |
503 |
Effects of
adenoviral gene transfer of C. elegans n-3 fatty acid
desaturase on the lipid profile and growth of human
breast cancer cells
Y Ge, Z Chen, JX Kang
Massachusetts General
Hospital/Harvard Medical School, Charlestown,
MA |
| 14:30 |
504 |
Identification of
oncogenes by proviral tagging in mouse cancer models I:
Sint1, a proto-oncogene belonging to the septin gene
family
AB Sorensen, S Warming, EM Füchtbauer, FS Pedersen
1Department
of Molecular and Structural Biology, and Department of
Medical Microbiology and Immunology, University of
Aarhus, Aarhus C, Denmark, 2Department of
Molecular and Structural Biology, University of Aarhus,
Aarhus, Denmark |
| 14:45 |
505 |
Adenovirus
mediated intratumoral E2F-1 gene therapy against
leiomyosarcoma in vitro and in vivo
SA Vorburger, N Hetrakul, M Wilson-Heiner, D Yu, RE
Pollock, B Feig, P Pisters, KK Hunt
Department of Surgical
Oncology, University of Texas, M.D. Anderson Cancer
Center, Houston, Tx United States |
| 15:00 |
506 |
Gene
quantification using multiplex real-time pcr: advantages
and limitations
D Klein
University of Veterinary
Sciences, Vienna, Austria |
| 15:15 |
507 |
*The role of PTEN
gene therapy in bladder cancer
HB Grossman, M Tanaka
The University of Texas
M. D. Anderson Cancer Center, Houston, TX |
| 15:30 |
508 |
Atlas of genetics
and cytogenetics in oncology and
haematology.
JL Huret, P Dessen, A Bernheim
1Department
of Medical Information, University Hospital, Poitiers,
France, 2Genetics and Oncology Villejuif,
France |
Poster Presentations
| Number |
Title / Authors / Affiliations |
| 509 |
Application of
novel tumor suppressor gene "ines" in nonviral gene
delivery for cancer gene therapy
H Yanagie, H Sugiyama, Y Furuya, Y Nonaka, Y Takeda, I
Yoshizaki, S Naka, H Shinnkawa, A Nojiri, H Niwa, K
Ariki, H Yasuhara, M Eriguchi, B Lee, S Li, L Huang, K
Maruyama
Teikyo University School
of Medicine, Ichihara Hospital, Ichihara, Chiba
Japan |
| 510 |
Application of
jts-1 fusogenic peptide to enhancement of transfection
efficiency in nonviral vector delivery for cancer gene
therapy
H Yanagie, K Maruyama, H Sugiyama, M Eriguchi, Y Nonaka,
Y Takeda, I Yoshizaki, Y Furuya, H Yasuhara, B Lee, S Li,
L Huang
1Teikyo
niversity, School of Medicine Ichihara Hospital, Chiba,
Japan, 2School of Pharmacy, Kanagawa, Japan,
3Nihon Medical University, Tokyo, Japan,
4Institute of Medical Science, University of
Tokyo, Tokyo, Japan, 5School of Pharmacy,
University of Pittsburgh, Pittsburgh, USA |
| 511 |
Enhancement of
transfection efficiency by jts-1 fusogenic peptide in
gastric cancer
Y Furuya, H Yanagie, S Okuda, M Iwasaki, S Naka, T
Nojiri, H Shinkawa, K Ariki, H Niwa, B Lee, S Li, L
Huang, M Eriguchi, H Yasuhara, K Maruyama
1Teikyo
University, Chiba, Japan, 2School of Pharmacy,
Kanagawa, Japan, 3School of Pharmacy,
University of Pittsburgh, Pittsburgh, USA,
4Institute of Medical Science, University of
Tokyo, Tokyo, Japan |
| 512 |
*Restoration of an
impaired TGF-beta1 autocrine growth-inhibitory circuit
using a gene transfer approach results in growth
inhibition of some epithelial cancer cell
lines.
Z Zeinoun, E Teugels, J Vermeij, B Neyns, J De
Greve
AZ-VUB, Brussels,
Brabant, Belgium |
| 513 |
Gene Transfer into
solid tumors - is a special application device beneficial
?
U Liebers, H Kuhn, B Schmidt, G Wolff, C Witt
1Dept. of
Pulmology, Medical School, Germany, Germany,
2of the Humboldt University Berlin, Germany,
Germany, 3Dept. of Pulmology, Medical Clinic,
Germany |
| 514 |
Contribution of a
combination of scopadulciol and acyclovir/ganciclovir to
the antitumor efficacy in HSV-TK gene therapy
system
K Hayashi, T Hayashi
Toyama Medical and
Pharmaceutical University, Toyama, Japan |
| 515 |
Cyclooxygenase-2
inducing mcl-1-dependent survival mechanism in human lung
adenocarcinoma cl1.0 cells: involvement of pi 3-k/akt
pathway
MLK Kuo
National Taiwan
University College of Medicine, Taipei, none
Taiwan |
| 516 |
Modified OPPA/COPP
chemotherapy for the treatment of Hodgkin disease in
Turkish children
S Gözdasoglu, E Üna, M Ertem, G Yavuz, A Pamir, N
Taçyildiz, Y Genç, AO Çavdar
1Divisions of
Pediatric Hematology and Oncology, Department of
Pediatrics School of Medicine, Ankara University, ,
2Cancer Committee, Turkish Academy of Sciences
and Pediatric Hematology-Oncology Research Centre Ankara
University Ankara - Turkey |
| 517 |
Predictive value
of quantitative DNA-analysis for patients with
cholangiocellular carcinoma
H Al-Abadi, S Jonas, T Steinmueller, I Rotter, P
Neuhaus
Department of Surgery,
Charite, Campus Virchow Klinikum, Humboldt University of
Berlin |
| 518 |
Interfeton alpha
inhibits intrahepatic recurrence in hepatocellular
carcinoma with chronic hepatitis C
S Maruyama, T Suou, Y Kishimoto, H Kawasaki, C
Hirayama
1Department
of Internal Medicine, Saiseikai Gotsu General Hospital,
Gotsu, Japan, 2Department of Pathobiological
Science and Technology, School of Health Science, Tottori
University, Yonago, Japan, 3Department of
Internal Medicine, San-in Rosai Hospital, Yonago,
Japan |
| 519 |
Switching to a
silenced metastatic phenotype by chromosome 18 transfer
into the pancreatic cancer cells
LP Lefter, M Sunamura, T Furukawa, K Takeda, S Matsuno, A
Horii
1First
Department of Surgery, 2Department of
Molecular Pathology; Tohoku University, Sendai, Miagy
Japan |
| 520 |
The prognostic
relevance of folylpolyglutamate synthetase (FPGS), γ
-glutamyl hydrolase (GGH), reduced folate carrier (RFC-1)
and thymidylate synthase (TS) gene expression levels in
patients with colorectal cancer.
E Odin, Y Wettergren, G Carlsson, L Larsson, BG
University of
Gothenburg, Sahlgrenska University Hospital/Ãstra,
Gothenburg, Sweden |
| 521 |
Equilibrium
phophorylated/dephosphorilated rb and p21 genes products
in pathological human prostates.
M Royuela, MI Arenas, J Alfaro, M Ricote, MVT Lobo, R
Vera, B Fraile, R Paniagua
University of Alcala,
Alcala de Henares, Madrid Spain |
| 522 |
The cAMP
responsive element a mediator construct between nerves
and enteroendocrine cell development
GE Holle, J Dietl, I Demir
Walther Straub
Inst.f.Pharmacology&Toxicology;, Germany, Munich,
Germany |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|
